# PROmyBETAappGame: a Study to Learn More About the Medication Usage & Patient Reported Outcomes Via the myBETAapp and to Find Out More About the Usage of Game Principles and Game Design Elements (Gamification) in Medical Care of Patients With Multiple Sclerosis Treated With Betaferon

> **NCT03808142** · — · COMPLETED · sponsor: **Bayer** · enrollment: 79 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **OTHER:** myBETAapp
- **OTHER:** PEAK
- **DRUG:** Betaferon, BAY86-5046
- **DEVICE:** BETACONNECT

## Key facts

- **NCT ID:** NCT03808142
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-20
- **Primary completion:** 2020-04-20
- **Final completion:** 2020-09-02
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03808142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03808142, "PROmyBETAappGame: a Study to Learn More About the Medication Usage & Patient Reported Outcomes Via the myBETAapp and to Find Out More About the Usage of Game Principles and Game Design Elements (Gamification) in Medical Care of Patients With Multiple Sclerosis Treated With Betaferon". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03808142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*